Profiling of glycans in serum for the discovery of potential biomarkers for ovarian cancer

Hyun Joo An, Suzanne Miyamoto, Katherine S. Lancaster, Crystal Kirmiz, Bensheng Li, Kit Lam, Gary S Leiserowitz, Carlito B Lebrilla

Research output: Contribution to journalArticle

175 Citations (Scopus)

Abstract

A glycomic approach is developed to identify oligosaccharide markers for ovarian cancer by rapidly profiling globally released oligosaccharides. Glycoproteins shed by cancer cells are found in the supernatant (or conditioned media) of cultured cells. In this approach, shed glycoproteins are profiled for their oligosaccharide content using β-elimination conditions. Changes in glycosylation are monitored by matrix-assisted laser desorption/ionization Fourier transform ion cyclotron resonance mass spectrometry (MALDI-FTICR-MS). Because shed glycoproteins would also be found in serum, similar glycan profiling was performed to observe potential oligosaccharide markers. Oligosaccharide profiling data on a limited set of patient and normal serum samples were studied to determine potential glycan markers in ovarian cancer. We were able to demonstrate the presence of at least 15 unique serum glycan markers in all patients but absent in normal individuals. To determine the structure of the glycan biomarkers, a number of the ions were isolated and further analyzed using infrared multiphoton dissociation (IRMPD). One major advantage of this approach is that glycans are examined directly from patient sera without the need to obtain cancer biopsy specimens or to purify glycosylated proteins from these specimens.

Original languageEnglish (US)
Pages (from-to)1626-1635
Number of pages10
JournalJournal of Proteome Research
Volume5
Issue number7
DOIs
StatePublished - Jul 2006

Fingerprint

Biomarkers
Oligosaccharides
Ovarian Neoplasms
Polysaccharides
Serum
Glycoproteins
Cells
Glycomics
Ions
Glycosylation
Cyclotrons
Cyclotron resonance
Biopsy
Fourier Analysis
Conditioned Culture Medium
Ionization
Mass spectrometry
Cultured Cells
Desorption
Mass Spectrometry

Keywords

  • Biomarker
  • Glycoprotein
  • MALDI
  • Mass spectrometry
  • Oligosaccharide
  • Ovarian cancer

ASJC Scopus subject areas

  • Genetics
  • Biotechnology
  • Biochemistry

Cite this

An, H. J., Miyamoto, S., Lancaster, K. S., Kirmiz, C., Li, B., Lam, K., ... Lebrilla, C. B. (2006). Profiling of glycans in serum for the discovery of potential biomarkers for ovarian cancer. Journal of Proteome Research, 5(7), 1626-1635. https://doi.org/10.1021/pr060010k

Profiling of glycans in serum for the discovery of potential biomarkers for ovarian cancer. / An, Hyun Joo; Miyamoto, Suzanne; Lancaster, Katherine S.; Kirmiz, Crystal; Li, Bensheng; Lam, Kit; Leiserowitz, Gary S; Lebrilla, Carlito B.

In: Journal of Proteome Research, Vol. 5, No. 7, 07.2006, p. 1626-1635.

Research output: Contribution to journalArticle

An, Hyun Joo ; Miyamoto, Suzanne ; Lancaster, Katherine S. ; Kirmiz, Crystal ; Li, Bensheng ; Lam, Kit ; Leiserowitz, Gary S ; Lebrilla, Carlito B. / Profiling of glycans in serum for the discovery of potential biomarkers for ovarian cancer. In: Journal of Proteome Research. 2006 ; Vol. 5, No. 7. pp. 1626-1635.
@article{f0040dee7a25425194fed52a8bae1343,
title = "Profiling of glycans in serum for the discovery of potential biomarkers for ovarian cancer",
abstract = "A glycomic approach is developed to identify oligosaccharide markers for ovarian cancer by rapidly profiling globally released oligosaccharides. Glycoproteins shed by cancer cells are found in the supernatant (or conditioned media) of cultured cells. In this approach, shed glycoproteins are profiled for their oligosaccharide content using β-elimination conditions. Changes in glycosylation are monitored by matrix-assisted laser desorption/ionization Fourier transform ion cyclotron resonance mass spectrometry (MALDI-FTICR-MS). Because shed glycoproteins would also be found in serum, similar glycan profiling was performed to observe potential oligosaccharide markers. Oligosaccharide profiling data on a limited set of patient and normal serum samples were studied to determine potential glycan markers in ovarian cancer. We were able to demonstrate the presence of at least 15 unique serum glycan markers in all patients but absent in normal individuals. To determine the structure of the glycan biomarkers, a number of the ions were isolated and further analyzed using infrared multiphoton dissociation (IRMPD). One major advantage of this approach is that glycans are examined directly from patient sera without the need to obtain cancer biopsy specimens or to purify glycosylated proteins from these specimens.",
keywords = "Biomarker, Glycoprotein, MALDI, Mass spectrometry, Oligosaccharide, Ovarian cancer",
author = "An, {Hyun Joo} and Suzanne Miyamoto and Lancaster, {Katherine S.} and Crystal Kirmiz and Bensheng Li and Kit Lam and Leiserowitz, {Gary S} and Lebrilla, {Carlito B}",
year = "2006",
month = "7",
doi = "10.1021/pr060010k",
language = "English (US)",
volume = "5",
pages = "1626--1635",
journal = "Journal of Proteome Research",
issn = "1535-3893",
publisher = "American Chemical Society",
number = "7",

}

TY - JOUR

T1 - Profiling of glycans in serum for the discovery of potential biomarkers for ovarian cancer

AU - An, Hyun Joo

AU - Miyamoto, Suzanne

AU - Lancaster, Katherine S.

AU - Kirmiz, Crystal

AU - Li, Bensheng

AU - Lam, Kit

AU - Leiserowitz, Gary S

AU - Lebrilla, Carlito B

PY - 2006/7

Y1 - 2006/7

N2 - A glycomic approach is developed to identify oligosaccharide markers for ovarian cancer by rapidly profiling globally released oligosaccharides. Glycoproteins shed by cancer cells are found in the supernatant (or conditioned media) of cultured cells. In this approach, shed glycoproteins are profiled for their oligosaccharide content using β-elimination conditions. Changes in glycosylation are monitored by matrix-assisted laser desorption/ionization Fourier transform ion cyclotron resonance mass spectrometry (MALDI-FTICR-MS). Because shed glycoproteins would also be found in serum, similar glycan profiling was performed to observe potential oligosaccharide markers. Oligosaccharide profiling data on a limited set of patient and normal serum samples were studied to determine potential glycan markers in ovarian cancer. We were able to demonstrate the presence of at least 15 unique serum glycan markers in all patients but absent in normal individuals. To determine the structure of the glycan biomarkers, a number of the ions were isolated and further analyzed using infrared multiphoton dissociation (IRMPD). One major advantage of this approach is that glycans are examined directly from patient sera without the need to obtain cancer biopsy specimens or to purify glycosylated proteins from these specimens.

AB - A glycomic approach is developed to identify oligosaccharide markers for ovarian cancer by rapidly profiling globally released oligosaccharides. Glycoproteins shed by cancer cells are found in the supernatant (or conditioned media) of cultured cells. In this approach, shed glycoproteins are profiled for their oligosaccharide content using β-elimination conditions. Changes in glycosylation are monitored by matrix-assisted laser desorption/ionization Fourier transform ion cyclotron resonance mass spectrometry (MALDI-FTICR-MS). Because shed glycoproteins would also be found in serum, similar glycan profiling was performed to observe potential oligosaccharide markers. Oligosaccharide profiling data on a limited set of patient and normal serum samples were studied to determine potential glycan markers in ovarian cancer. We were able to demonstrate the presence of at least 15 unique serum glycan markers in all patients but absent in normal individuals. To determine the structure of the glycan biomarkers, a number of the ions were isolated and further analyzed using infrared multiphoton dissociation (IRMPD). One major advantage of this approach is that glycans are examined directly from patient sera without the need to obtain cancer biopsy specimens or to purify glycosylated proteins from these specimens.

KW - Biomarker

KW - Glycoprotein

KW - MALDI

KW - Mass spectrometry

KW - Oligosaccharide

KW - Ovarian cancer

UR - http://www.scopus.com/inward/record.url?scp=33745913025&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745913025&partnerID=8YFLogxK

U2 - 10.1021/pr060010k

DO - 10.1021/pr060010k

M3 - Article

C2 - 16823970

AN - SCOPUS:33745913025

VL - 5

SP - 1626

EP - 1635

JO - Journal of Proteome Research

JF - Journal of Proteome Research

SN - 1535-3893

IS - 7

ER -